PACpAInt: a deep learning approach to identify molecular subtypes of pancreatic adenocarcinoma on histology slides
Charlie Saillard(Laboratoire Procédés et Ingénierie en Mécanique et Matériaux), J. Cros(Inserm), Armelle Bardier–Dupas(Sorbonne Université), Vinciane Rebours(Hôpital Beaujon), Benoît Schmauch(Owl Research Institute), Cindy Neuzillet, Louis de Mestier(Inserm), Magali Svrcek(Azienda Unita' Sanitaria Locale Di Modena), Aurélie Kamoun(La Ligue Contre le Cancer), Pierre Courtiol, Rémy Nicolle(Centre National de la Recherche Scientifique), F. Delecourt(Inserm), Mikhail Zaslavskiy, Valérie Paradis(Centre National de la Recherche Scientifique), Jean‐Baptiste Bachet(Université Paris Cité), Pascal Hammel(Université Paris Cité), Yasmina Kermezli(Centre National de la Recherche Scientifique), J. Iovanna(Centre National de la Recherche Scientifique), Magali Richard(Centre National de la Recherche Scientifique), Olivier Moindrot, Yuna Blum(Centre National de la Recherche Scientifique), Nelson Dusetti(Inserm), J-F. Emile(Université de Versailles Saint-Quentin-en-Yvelines), Mira Ayadi(IntegraGen (France))
Cited by 3
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.8k
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
|Journal of Clinical Oncology|2018|2.1k
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial
|The Lancet Oncology|2021|1.3k
A deep learning model to predict RNA-Seq expression of tumours from whole slide images
|Nature Communications|2020|524
Chronic pancreatitis
|Nature Reviews Disease Primers|2017|447